Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-24-009803
Filing Date
2024-02-01
Accepted
2024-02-01 16:15:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2943
  Complete submission text file 0000950170-24-009803.txt   4389
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address
Sommadossi Jean-Pierre (Reporting) CIK: 0001296995 (see all company filings)

Type: 144

Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Subject) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39661 | Film No.: 24587105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)